Business Context and Reporting Period
Company: Advanced Flower Capital Inc. (AFCG)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2025
Business Overview: AFCG is an institutional lender specializing in senior secured loans to cannabis industry operators and ancillary businesses. The company operates as a Real Estate Investment Trust (REIT) but is in the process of converting to a Business Development Company (BDC). In July 2024, the company completed a spin-off of its commercial real estate portfolio into Sunrise Realty Trust, Inc. (SUNS), which is now reported as discontinued operations.
Key Financial Metrics
| Metric | Q3 2025 (3 Months) | YTD 2025 (9 Months) | YTD 2024 (9 Months) |
|---|---|---|---|
| Interest Income | $8.16 million | $24.68 million | $42.77 million |
| Net Interest Income | $6.53 million | $19.38 million | $38.02 million |
| Total Expenses | $2.81 million | $7.89 million | $13.73 million |
| Provision for Credit Losses | $(7.37) million | $(22.52) million | $1.15 million |
| Unrealized Losses on Loans (Fair Value) | $(9.71) million | $(11.45) million | $(9.66) million |
| Net Loss (Continuing Ops) | $(12.49) million | $(21.59) million | $14.85 million |
| Net Loss (Total) | $(12.49) million | $(21.59) million | $17.78 million |
| Cash and Equivalents | $45.12 million | $45.12 million | $122.16 million |
| Total Debt (Senior Notes + Revolver) | $111.06 million | $111.06 million | $148.61 million |
| Book Value Per Share | $7.49 | $7.49 | $9.02 |
Material Changes vs. Prior Period
- Significant Net Loss: The company reported a net loss of $12.49 million for Q3 2025, compared to net income of $1.38 million in Q3 2024. This reversal is primarily driven by a $7.37 million provision for current expected credit losses (CECL) and a $9.71 million unrealized loss on loans held at fair value.
- Decline in Interest Income: Interest income decreased 21.9% quarter-over-quarter and 42.3% year-over-year (YTD). This decline is attributed to multiple loans being placed on nonaccrual status (Private Company A, P, G, and K) and fewer loan exits/prepayments compared to the prior year.
- Increased Credit Reserves: The CECL reserve increased significantly to $51.3 million (18.69% of loans held at carrying value) from $30.6 million (10.36%) at year-end 2024, reflecting deteriorating credit quality in the portfolio.
- Debt Reduction: Total debt decreased as the company repaid $148.6 million on revolving credit facilities while borrowing $70.6 million, resulting in a net reduction of revolver usage from $60 million to $22 million. The affiliate credit facility was terminated in April 2025.
- Dividend Reduction: Dividends declared per share dropped to $0.15 in Q3 2025 from $0.33 in Q3 2024. Management does not anticipate paying a dividend in Q4 2025 due to expected taxable losses from loan settlements.
Guidance, Outlook, and Risks
- BDC Conversion: Shareholders approved the Investment Advisory Agreement on November 6, 2025, a necessary step to convert from a REIT to a BDC. This conversion aims to expand the investment universe to include non-real estate assets and ancillary cannabis businesses. The Board will consider remaining matters to effect the conversion in coming months.
- Investment Strategy Expansion: The Board approved an amendment to the Management Agreement to expand lending to companies ancillary to the cannabis industry and outside the cannabis sector to diversify risk.
- Loan Portfolio Stress: Four loans are currently on nonaccrual status, totaling approximately $155 million in outstanding principal. Significant unrealized losses were recognized on the loan to Private Company A (held at fair value), which is in receivership.
- Subsequent Events & Settlements:
- Private Company A: Received $4.2 million in payments from collateral sales in October 2025.
- Private Company P: Entered a settlement agreement in November 2025 for $13.3 million. The company expects to realize a taxable loss of approximately $4.1 million upon closing, impacting Q4 distributable earnings.
- Liquidity: Management believes cash on hand ($45.1 million) and revolver capacity ($28 million available) are sufficient for operations for the next 12 months, despite the suspension of the ATM program.
Investor Verification Checklist
- Non-Accrual Exposure: Verify the specific recovery prospects for the four loans on nonaccrual status, particularly the $78.9 million loan to Subsidiary of Private Company G and the $51.0 million loan to Private Company A.
- BDC Conversion Timeline: Monitor the Board's progress on finalizing the conversion to a BDC, as this will alter the company's regulatory framework and investment capabilities.
- Dividend Sustainability: Confirm the impact of the expected $4.1 million taxable loss from the Private Company P settlement on Q4 2025 distributable earnings and future dividend declarations.
- CECL Reserve Adequacy: Assess whether the 18.69% reserve coverage is sufficient given the concentration of risk in the cannabis sector and the current macroeconomic environment.
- Legal Proceedings: Track the status of the lawsuit filed by Private Company G in California, which alleges mismanagement and wrongful seizure of assets.